Private Advisor Group’s Celgene Corporation Contingent Value Rights CELGZ Stock Holding History

Private Advisor Group’s Portfolio CELGZ Stock Details CELGZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-30,000	Closed	-$15K	–	1791
2019 Q3	$15K	Buy	+30,000	New	+$16.7K	﹤0.01%	1639

Private Advisor Group's CELGZ Position: Q4 2019 in Review

Private Advisor Group sold out of Celgene Corporation Contingent Value Rights (CELGZ) in Q4 2019, closing a stake of 30,000 shares — an estimated $15K sold.

Private Advisor Group first reported a position in CELGZ in Q3 2019 and held it in 1 quarter. The position peaked at $15K in Q3 2019. 0 funds tracked by Wall St. Rank hold CELGZ as of Q4 2019.

Private Advisor Group reported no remaining Celgene Corporation Contingent Value Rights position as of Q4 2019 after selling out during the quarter.
Private Advisor Group sold 30,000 Celgene Corporation Contingent Value Rights shares in Q4 2019, an estimated $15K.
Private Advisor Group first reported a position in Celgene Corporation Contingent Value Rights in Q3 2019 and held it in 1 quarter.
Private Advisor Group's Celgene Corporation Contingent Value Rights position peaked at $15K in Q3 2019.
0 funds tracked by Wall St. Rank held Celgene Corporation Contingent Value Rights as of Q4 2019.

Based on Private Advisor Group's 13F filing for Q4 2019, filed 10 Feb 2020.